ArticleOncology letters2012
Metastatic gastric tumors arising from renal cell carcinoma: Clinical characteristics and outcomes of this uncommon disease.
Article in Oncology letters, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 26 citations in OpenAlex.
- Article
- Article
- Hybrid Endoscopic Submucosal Dissection for Isolated Gastric Metastasis of Renal Cell Carcinoma.ACG case reports journal · 2024Article
- Rare Case of Metachronous Gastric Metastasis from Primary Ovarian Carcinoma.Indian journal of surgical oncology · 2024Article
- Article
- Case report: Uncommon gastric metastasis as a presentation of recurrent clear cell renal cell carcinoma.Frontiers in oncology · 2024Article
- Discovery of Gastric Metastases From Primary Renal Cell Carcinoma Through MRI: A Case Report.Cureus · 2023Article
- Gastric metastasis presenting as submucosa tumors from renal cell carcinoma: A case report.World journal of clinical cases · 2022Article
- Metastatic Renal Cell Carcinoma Manifesting as a Gastric Polyp on CT: A Case Report and Literature Review.Taehan Yongsang Uihakhoe chi · 2022Article
- Application ofJournal of oncology · 2022Article
- Gastrointestinal Metastases From Primary Renal Cell Cancer: A Single Center Review.Frontiers in oncology · 2021Article
- Secondary involvement of the gastrointestinal tract by renal cell carcinoma.Proceedings (Baylor University. Medical Center) · 2018Article
- Simultaneous Gastric Metastasis From Renal Cell Carcinoma: A Case Report and Literature Review.Clinical medicine insights. Case reports · 2018Article
- Clinical presentation and treatment of gastric metastasis from other malignancies of solid organs.Biomedical reports · 2017Article
- A case of gastric metastasis from renal cell cancer during the sequential targeted therapy.International cancer conference journal · 2017Article
- A Rare Case of the Simultaneous, Multifocal, Metastatic Renal Cell Carcinoma to the Ipsilateral Left Testes, Bladder, and Stomach.Case reports in urology · 2016Article
- Clinicopathological features and treatment outcomes of metastatic tumors in the stomach.Surgery today · 2014Review
- Treatment of gastric metastases from renal cell carcinoma with endoscopic therapy.Clinical journal of gastroenterology · 2014Article
- Gastric metastasis from renal cell carcinoma with gastrointestinal bleeding: a case report and review of the literature.International surgeryReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We analyzed the clinicopathological characteristics and therapeutic outcomes of patients with metastatic gastric tumors arising from renal cell carcinoma (RCC) to identify post-therapy prognostic factors. A total of 22 patients who were treated for metastatic gastric tumors arising from RCC were included in the study. A retrospective review was performed on the clinical characteristics of this disease. The median time interval from radical excision of the primary tumor to the detection of gastric metastasis (IGM) was 6.3 years. The overall 1- and 3-year survival rates were 52.6 and 21.0%, respectively, and the median survival time was 19 months. Compared with patients with an IGM of <6.3 years, patients with an IGM of ≥6.3 years showed a significantly longer median survival time (5 vs. 24 months; P=0.017). The median tumor size was significantly greater in patients with multiple metastases compared with those with solitary metastasis (4 vs. 2 cm; P=0.036). The incidence of patients who had undergone therapeutic tumor resection was significantly higher in patients with solitary metastasis compared with those with multiple metastases (100.0 vs. 35.7%; P=0.019). The appearance of gastric tumors in patients with a history of RCC should prompt the clinician to investigate the possibility of metastasis even several years after detection of the original renal cancer. A longer interval from nephrectomy to the diagnosis of gastric metastasis is generally indicative of a better prognosis, most likely the result of less aggressive tumor growth.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.